Science · Comparative Biology

Сравнительная онкология

Эволюция уже решила задачу рака. Несколько раз. У разных видов. Просто посмотрим в правильные геномы.

Animals, которые не болеют раком

Не все species развили evolutionary cancer-resistance стратегии одинаково. Каждое решение — discovery, который мы можем reverse-engineer:

🐘 Слоны (Loxodonta africana, Elephas maximus)

~5% lifetime cancer mortality vs ~17-25% у людей. Mechanism: TP53 retrogene expansion (~20 copies vs human 1) + LIF6 reactivation (mitochondrial kill switch). Aggressive p53-driven apoptosis любой damaged cell. Это наша primary inspiration.

🐭 Naked mole rats (Heterocephalus glaber)

Long-lived (до 30 лет — exceptional для grizun), virtually cancer-free. Mechanism: high-molecular-weight hyaluronic acid в extracellular matrix triggers contact inhibition в density-dependent way. Они также имеют hyperactive p53 и Rb pathways, что fails most tumorigenic mutations. Plus enhanced проteasome activity, removing damaged proteins fast.

🐋 Bowhead whales (Balaena mysticetus)

200+ years lifespan, ~100,000x наше body cell count, essentially zero detectable cancer. Mechanism (partial): expanded set of DNA repair genes (включая ERCC1, PCNA, LAMTOR1 duplications), enhanced cell cycle checkpoint, slower somatic mutation accumulation. Genome sequenced 2015 Keane et al.

🦇 Bats (Microchiroptera, Myotis spp.)

Some bat species live 30-40 лет (extraordinary для small mammal), redused cancer rates. Mechanism: enhanced DNA damage repair, dampened inflammasome response (which prevents inflammation-driven cancer), efficient autophagy.

Animals, которые часто болеют раком

Comparative oncology также teaches от species, которые имеют high cancer rates:

• Tasmanian devils — endangered partly из-за contagious facial tumor (DFTD). Tumor cells можно transfer между animals at bites. Это unique cancer transmission case.
• Golden retrievers — ~60% develop cancer (lymphoma, hemangiosarcoma). Genetic susceptibility from breed bottleneck.
• Cattle — bovine leukemia virus causes lymphoma. Viral cancers underappreciated в human medicine.

Что comparative oncology teaches

Главный takeaway: cancer resistance — evolvable trait. Эволюция несколько раз discovered, как делать животных large и long-lived без proportional cancer increase. Mechanisms varied, но common themes emerge:

• Multiple redundant tumor suppressor genes (TP53 copies в слонах)
• Aggressive apoptotic triggers downstream damage detection (LIF6 в слонах)
• Enhanced DNA repair machinery (bowhead whales)
• Contact inhibition и density-dependent growth control (naked mole rats)
• Damp inflammation pathways (bats)

Therapeutic implication

Если evolution found multiple anti-cancer strategies в разных species, можем engineer этих strategies обратно в human tumors? Этот вопрос driving comparative-oncology-informed drug discovery.

Nightbox's NKG2D-LIF6 chimera — one такой attempt: take elephant cancer-resistance mechanism (LIF6 mitochondrial kill switch), re-gate его на tumor-specific recognition (NKG2D-MICA/MICB), deliver через AAV9. Result, in principle: tumor cell expresses construct, NKG2D portion binds tumor stress ligands ON THE SAME CELL, LIF6 portion triggers apoptosis. Tumor cell suicide signal, evolutionarily validated в слонах.

Key references

• Abegglen et al. (2015), JAMA 314:1850 — elephant TP53 expansion и comparative cancer rates.
• Vazquez et al. (2018), Cell Reports 24:1765 — elephant LIF6 reactivation.
• Tian et al. (2013), Nature 499:346 — naked mole rat high-molecular-weight hyaluronan.
• Keane et al. (2015), Cell Reports 10:112 — bowhead whale genome.
• Tollis et al. (2017), BMC Biology 15:60 — Peto's paradox у whales и dolphins.

Написано Артёмом Шакиным, founder Nightbox LLC. Published 2026-04-30. CC BY 4.0.